Inamed
Executive Summary
Yamanouchi America President Nicholas Teti joins the medical device company as president and CEO Aug. 1. Teti replaces Richard Babbitt as CEO; Babbitt will continue as Inamed chairman. Teti was previously DuPont Pharma president & CEO. He retired, after 25 years with the company, at the end of 2000